ACE and myocardial infarction: The ACE Inhibitor Myocardial Infarction Collaborative Group contributed to this through a systematic review of short-term trials such as ISIS-4, CCS-1, CONSENSUS-II, GISSI-3, SMILE, GISSI-3 Pilot, ISIS-4 Pilot and several smaller studies in which ACE inhibitor treatment with captopril (in ISIS-4, CCS-1), enalapril (in CONSENSUS-II), lisinopril (in GISSI-3), and zofenopril (in SMILE) was stared early after MI and continued up to six weeks [228].